Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
DP-VPA
Also known as: SPD 421
print preview
bookmark
share with colleague
General Information
Company
D-Pharm Ltd.
Description
Phospholipid derivative of valproic acid formulated with Regulated Activation of Prodrugs (D-RAP) technology
Molecular Target
Histone deacetylase (HDAC)
Mechanism of Action
Histone deacetylase (HDAC) inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy